EVOGENE WKN: A0Q7UP ISIN: IL0011050551 Kürzel: E3V Forum: Aktien Thema: Hauptdiskussion

Biomica Announces Positive Pre-Clinical Results, Demonstrating Efficacy of BMC128 in Melanoma https://www.prnewswire.com/news-releases/biomica-announces-positive-pre-clinical-results-demonstrating-efficacy-of-bmc128-in-melanoma-301267404.html Biomica's live biotherapeutic drug candidate, BMC128, significantly increased anti-tumor activity in combination with Immune Checkpoint Inhibitors in Melanoma. First-in-human, proof of concept study expected later this year

Evogene Reports First Quarter 2021 Financial Results https://www.marketscreener.com/quote/stock/CORTEVA-INC-59241389/news/Corteva-nbsp-Evogene-Reports-First-Quarter-2021-Financial-Results-Evogene-33357979/ Evogene Q1 EPS $(0.17) Up From $(0.24) YoY, Sales $333.00K Beat $300.00K Estimate https://www.benzinga.com/news/earnings/21/05/21294854/evogene-q1-eps-0-17-up-from-0-24-yoy-sales-333-00k-beat-300-00k-estimate Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.17) per share. This is a 29.17 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $333.00 thousand which beat the analyst consensus estimate of $300.00 thousand by 11.00 percent. This is a 344.00 percent increase over sales of $75.00 thousand the same period last year.

Evogene : AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate https://www.marketscreener.com/quote/stock/EVOGENE-LTD-56536833/news/Evogene-nbsp-AgPlenus-Announces-Positive-Results-for-a-Herbicide-Resistance-Trait-to-its-Leading-H-35797014/

Evogene Reports Second Quarter 2021 Financial Results https://finance.yahoo.com/news/evogene-reports-second-quarter-2021-110000165.html https://www.earningswhispers.com/epsdetails/evgn Evogene Ltd Ord (EVGN) reported a 2nd Quarter June 2021 loss of $0.15 per share on revenue of $0.1 million. on revenue of $0.3 million. Revenue fell 54.7% compared to the same quarter a year ago.

Evogene : Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in Israel https://www.marketscreener.com/quote/stock/EVOGENE-LTD-120962472/news/Evogene-Canonic-Announces-Pre-Launch-of-its-First-Generation-Medical-Cannabis-Products-in-Israel-36288842/ Pre-launch of G-nnovation product line to a limited number of patients; Full commercial launch expected in 2022

Heftig, wie der Wert hier zerissen wird seit Tagen. Mehr als 50% gefallen. Komplette Übertreibung. Gut gelaufen hin oder her...

Evogene Reports Fourth Quarter and Full Year 2020 Financial Results https://www.prnewswire.com/news-releases/evogene-reports-fourth-quarter-and-full-year-2020-financial-results-301239537.html

Hammer Performance!

🍀

Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium https://finance.yahoo.com/news/evogene-provides-2020-end-crispr-120000314.html

Lavie Bio Provides Product Pipeline Update for 2020 https://www.prnewswire.com/news-releases/lavie-bio-provides-product-pipeline-update-for-2020-301198936.html LAV211 bio-stimulant advancing towards anticipated 2022 commercial launch in spring wheat; Product advancement achieved in multiple programs Lavie Bio Ltd. (Lavie Bio), a leading ag-biologicals company focusing on improving food quality, sustainability and agriculture productivity through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has announced an update on certain advancements achieved in its pipeline in 2020, including phase advancement of bio-stimulant LAV211, towards an anticipated commercial launch in 2022. ...

👍

löppt

🍀

Wunderschön :)